Guí a OncoSur de me l anoma 18 > 18. Qi L, Qi X, Xiong H, et al. Type 2 diabetes mellitus and risk of malignant melanoma: A systematic review and meta-analysis of cohort studies. Iranian J Publ Health 2014;43:857-66. 19. De Giorgi V, Gori A, Savarese IJ, et al. Role of BMI and hormone therapy in melanoma risk: a case-control study. Cancer Res Clin Oncol 2017. DOI: 10.1007/s00432-017-2387-5 20. Caini S, Masala G, Saieva C, et al. Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2017;140(10):2246-55. DOI: 10.1002/ijc.30659 21. Wang J, Li X, Zhang D. Coffee consumption and the risk of cutaneous melanoma: a meta-analysis. Eur J Nutr 2016;55:1317-29. 22. Yew YW, Lai YC, Schwartz RA. Coffee Consumption and Melanoma: A Systematic Review and Meta-Analysis of Observational Studies. Am J Clin Dermatol 2016;17:113-23. 23. Nagore E, Hueso L, Botella-Estrada R, et al. Smoking, sun exposure, number of nevi and previous neoplasia are risk factors for melanoma in older patients (60 years and over). J Eur Acad Dermatol Venereol 2010;24:50-7. DOI: 10.1111/j.1468-3083.2009.03353.x 24. Dennert G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database Syst Rev 2011;11(5):CD005195. DOI:10.1002/14651858.CD005195.pub2 25. Park SM, Li T, Wu S, et al. Niacin intake and risk of skin cancer in US women and men. Int J Cancer 2017. DOI: 10.1002/ijc.30630 26. Park SM, Li T, Wu S, et al. Vitamin D intake and risk of skin cancer in US women and men. PLOSone 2016. DOI:10.1371/journal.pone.0160308 27. Caini S, Boniol M, Tosti G, et al. Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis. Eur J Cancer 2014;50:2649-58. DOI: 10.1016/j.ejca.2014.06.024 28. Gandini S, Raimondi S, Gnagnarella P, et al. Vitamin D and skin cancer: a meta-analysis. Eur J Cancer 2009;45:634-41. DOI: 10.1016/j.ejca.2008.10.003 29. Druesne-Pecollo N, Latino-Martel P, Norat T, et al. Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer 2010;127:172-84. 30. Freeman SR, Drake AL , Heilig LF , et al. Statins, fibrates, and melanoma risk: a systematic review and meta- analysis J Natl Cancer Inst 2006;98:1538-46. 31. Browning DR, Martin RM. Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer 2007;120:833-43. 32. Vuadens A, Ackermann S, Levi F, et al. Sun-related knowledge and attitudes of primary and secondary school children in western Switzerland. Eur J Cancer Prev 2016. DOI: 10.1097/CEJ.0000000000000279 33. Madronio CM,Armstrong BK, Watts CG, et al. Doctors’ recognition and management of melanoma patients’ risk: An Australian population-based study. J Cancer Epidemiol 2016;45:32-9. DOI: 10.1016/j.canep.2016.09.006. Epub 2016 Sep 28 34. Wu YP, Aspinwall LG, Nagelhout E, et al. Development of an Educational Program Integrating Concepts of Genetic Risk and Preventive Strategies for Children with a Family History of Melanoma. J Cancer Educ 2016. DOI:10.1007/s13187-016-1144-9 35. Rodríguez VM, Berwick M, Hay JL, et al. Communication about melanoma and risk reduction after melanoma diagnosis. Psychooncology 2016. DOI: 10.1002/pon.4315 36. Watts CG, Madronio CM, Morton RL, et al. Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, Australia. Australas J Dermatol 2016. DOI: 10.1111/ajd.12530 37. Frank C, Sundquist J, Hemminki A, et al. Risk of other cancers in families with melanoma: novel familial links. Sci Rep 2017;7:42601. DOI: 10.1038/srep42601 38. Frank C, Fallah M, Sundquist J, et al. Population landscape of familial cancer. Sci Rep 2015;5:12891. DOI: 10.1038/srep12891 39. De Simone P, Valiante M, Silipo V. Familial melanoma and multiple primary melanoma. Giornale Italiano di Dermatologia e Venereologia 2017;24. DOI: 10.23736/S0392-0488.17.05554-7 40. Mangas C, Potrony M, Mainetti C, et al. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF. Br J Dermatol 2016;175:1030-7. DOI: 10.1111/bjd.14897. Epub 2016 Aug 31 41. Nagore E, Botella-Estrada R, García-Casado Z, et al. Comparison between familial and sporadic cutaneous melanoma inValencia, Spain. J EurAcad Dermatol Venereol 2008;22:931-6. DOI: 10.1111/j.1468-3083.2008.02682.x 42. Menin C, Bojnik E, del Bianco P, et al. Differences in telomere length between sporadic and familial cutaneous melanoma. Br J Dermatol 2016;175:937-43. DOI: 10.1111/bjd.14652 43. Rai K, Pilarski R, Boru G, et al. Germline BAP1 alterations in familial uveal melanoma. Genes Chromosomes Cancer 2017;56:168-74. DOI: 10.1002/gcc.22424
RkJQdWJsaXNoZXIy OTI4NTYw